PPIPT01384
Target Protein Information
| Protein_Name | GTPase KRas |
|---|---|
| Protein_Sequence | MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM |
| Organism_Source | Homo sapiens |
| Functional_Classification | Small GTPase (Ras family) |
| Cellular_Localization | Plasma membrane |
| Gene_Names | KRAS |
| UniProt_ID | P01116 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | R4000 |
|---|---|
| Peptide_Sequence | XCYXKHXXXXYXC |
| Peptide_Length | 13 |
| Peptide_SMILES | NCCCC[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)CN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)O |
| Chemical_Modification | X1=Norvaline; X4=u-tert-butylglycine; X7=N-methylalanine; X8=phenylglycine; X9=7-azatryptophan; X11=4-fluorophenylglycine; X13=sarcosine |
| Cyclization_Method | Side chain cyclization; C2<->C13; other bonds |
| Linear/Cyclic | Linear |
| N-terminal_Modification | Acetyl |
| C-terminal_Modification | Amide |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 1215.32 |
|---|---|
| Aliphatic_Index | 0.00000 |
| Aromaticity | 0.15385 |
| Average_Rotatable_Bonds | 2.84615 |
| Charge_at_pH_7 | 0.96295 |
| Isoelectric_point | 8.22461 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 20 |
| Number_of_Hydrogen_Bond_Donors | 20 |
| Topological_Polar_Surface_Area | 507.68000 |
| X_logP_energy | -7.51330 |
Interaction Information
| Affinity | KD=4.4 nM |
|---|---|
| Affinity_Assay | Surface Plasmon Resonance |
| PDB_ID | None |
| Type | Antagonist |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | RAS BINDING PEPTIDES AND METHODS OF USE |
| Release_Year | 2019 |
| Patent_ID | US20190119358A1 |